Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
27.13
+1.91 (7.57%)
Nov 22, 2024, 4:00 PM EST - Market closed
Galapagos NV Employees
Galapagos NV had 1,123 employees as of December 31, 2023. The number of employees decreased by 215 or -16.07% compared to the previous year.
Employees
1,123
Change (1Y)
-215
Growth (1Y)
-16.07%
Revenue / Employee
$258,316
Profits / Employee
$204,924
Market Cap
1.74B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
10x Genomics | 1,259 |
AtriCure | 1,200 |
GoodRx Holdings | 694 |
Clover Health Investments | 552 |
Recursion Pharmaceuticals | 500 |
Immunocore Holdings | 497 |
Arvinas | 445 |
Dynavax Technologies | 408 |
GLPG News
- 18 days ago - Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 - GlobeNewsWire
- 23 days ago - Galapagos NV (GLPG) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth - GlobeNewsWire
- 7 weeks ago - Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos' CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area - Business Wire
- 7 weeks ago - Galapagos receives transparency notification from EcoR1 Capital - GlobeNewsWire
- 2 months ago - Galapagos receives transparency notification from FMR LLC - GlobeNewsWire
- 3 months ago - Galapagos: CAR-T Biotech To Change Landscape With GLPG5101 And Beyond - Seeking Alpha